Connect with us
https://tickernews.co/wp-content/uploads/2023/10/AmEx-Thought-Leaders.jpg

News

Here’s when to expect a Pfizer jab if you’re under 40

Published

on

The head of Australia’s Covid-19 taskforce says Australian’s under the age of 40 can expect to be eligible to receive a Pfizer or Moderna Covid jab around September or October

Most Australians under 40 are currently not eligible for Pfizer or Moderna, but can opt to receive the AstraZeneca jab, according to the head of the COVID-19 vaccine taskforce.

Supplies of Pfizer and Moderna are expected to massively ramp up in the coming months, but nearly 8,000 younger Australians have opted to receive the AstraZeneca jab instead.

Lieutenant General John Frewen has told the ABC that younger Australians could be given a choice as to which mRNA jab they receive, once enough doses arrive and access is expanded.

“We’re seeing demand right now in that group of people to take AstraZeneca now rather than wait for an alternate later in the year,” he said.

“When we have adequate supplies, I think that’s a logical step.”

Health officials have previously warned younger Australians against the AstraZeneca vaccine due to rare but potentially deadly blood clots.

“AstraZeneca is open to under 40s with informed consent with their GPs.”

This deadline comes as millions of the nation’s residents remain in lockdown due to Covid outbreaks.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

News

Markets brace for pivotal week following renewed US-China trade talks

Global markets brace for US-China trade talks, earnings, and inflation data impacting investor sentiment and central bank outlook.

Published

on

Global markets brace for US-China trade talks, earnings, and inflation data impacting investor sentiment and central bank outlook.


Global markets prepare for a critical week as US–China trade talks, major earnings, and inflation data could shift investor sentiment and central bank expectations.

Kyle Rodda from Capital.com breaks down the key risks and opportunities.

#GlobalMarkets #USChinaTrade #Inflation #EarningsSeason #Investing #FederalReserve #AUD #Tesla #Netflix #MarketUpdate


Download the Ticker app

Continue Reading

News

Global markets steady ahead of CPI

Global equities stay strong near record highs as investors await US CPI data to assess central bank decisions.

Published

on

Global equities stay strong near record highs as investors await US CPI data to assess central bank decisions.


Global equities remain resilient, with Wall Street, Europe, and Asia near record highs as investors eye Friday’s US CPI data to gauge central bank moves.

Market watchers note cautious optimism amid ongoing volatility.

#GlobalMarkets #CPI #WallStreet #Equities #Investing #CentralBanks #RBA #Fed #USMarkets #MarketUpdate


Download the Ticker app

Continue Reading

News

US sanctions Russia’s top oil giants

US sanctions on Rosneft and Lukoil aim to pressure Moscow amid oil price surges; impact depends on enforcement.

Published

on

US sanctions on Rosneft and Lukoil aim to pressure Moscow amid oil price surges; impact depends on enforcement.


The US has imposed new sanctions on Rosneft and Lukoil, aligning with Europe to pressure Moscow amid rising oil prices and global market tensions.

Analysts warn the real impact will hinge on enforcement and international response.

#Russia #USSanctions #Rosneft #Lukoil #OilMarkets #Geopolitics #EnergyCrisis #DonaldTrump #EU #GlobalTrade #Moscow


Download the Ticker app

Continue Reading

Trending Now